Displaying drugs 10001 - 10025 of 12591 in total
ORP-101
ORP-101 is under investigation in clinical trial NCT04129619 (A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)).
Investigational
Matched Iupac: … azahexacyclo[13.2.2.1^{2,8}.0^{1,6}.0^{6,14}.0^{7,12}]icosa-7(12),8,10-trien-16-yl]-3,3-dimethylbutan-2-ol …
Matched Description: … ORP-101 is under investigation in clinical trial NCT04129619 (A Comparison of the Effects of ORP-101 …
Matched Description: … ORP-101 is under investigation in clinical trial NCT04129619 (A Comparison of the Effects of ORP-101 …
CRA_23653
Experimental
Idazoxan
Idazoxan has been used in trials studying the basic science of Molecular Imaging, Alzheimer Disease, and Major Depressive Disorder.
Investigational
Matched Description: … Idazoxan has been used in trials studying the basic science of Molecular Imaging, Alzheimer Disease, …
Fenozolone
Experimental
Carbuterol
Experimental
Nordazepam
An intermediate in the metabolism of DIAZEPAM to OXAZEPAM. It may have actions similar to those of diazepam.
Experimental
Matched Description: … It may have actions similar to those of diazepam. ... An intermediate in the metabolism of DIAZEPAM to OXAZEPAM. …
Creatinine
Creatinine has been used in trials studying the treatment of Amyotrophic Lateral Sclerosis.
Investigational
Matched Description: … Creatinine has been used in trials studying the treatment of Amyotrophic Lateral Sclerosis. …
Kaempherol
Experimental
CRA_9076
Experimental
Banoxantrone
Banoxantrone is a highly selective bioreductive drug that is activated in, and is preferentially toxic to, hypoxic cells in tumours. It has been shown to work synergistically with fractionated radiation to significantly delay growth of tumours compared to administration of either banoxantrone or radiation alone. Banoxantrone was also efficacious in...
Investigational
Matched Description: … tumours compared to administration of either banoxantrone or radiation alone. ... It has been shown to work synergistically with fractionated radiation to significantly delay growth of …
AZD-3839
AZD3839 has been used in trials studying the basic science of Safety, Tolerability, Alzheimer's Disease, and Blood Concentration.
Investigational
Matched Description: … AZD3839 has been used in trials studying the basic science of Safety, Tolerability, Alzheimer's Disease …
GO-203-2C
GO-203-2C is under investigation in clinical trial NCT02204085 (A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia).
Investigational
Matched Iupac: … hydroxypentylidene]amino}-1-hydroxypentylidene]amino}-1-hydroxyhexylidene]amino}-3-(C-hydroxycarbonimidoyl)propanoic acid …
Matched Description: … GO-203-2C is under investigation in clinical trial NCT02204085 (A Phase I/II Trial of the MUC1 Inhibitor …
Matched Description: … GO-203-2C is under investigation in clinical trial NCT02204085 (A Phase I/II Trial of the MUC1 Inhibitor …
CRA_10655
Experimental
Carbazochrome
Carbazochrome is a hemostatic agent that promotes clotting, preventing blood loss from open wounds. It is an oxidation product of adrenaline which enhances the microcirculatory tone . In the future this may prevent excessive blood flow during surgical operations and the treatment of hemorrhoids, but research on effectiveness and severity...
Experimental
Withdrawn
Matched Description: … in a number of countries. ... , but research on effectiveness and severity of side effects remains inconclusive. ... It is an oxidation product of adrenaline which enhances the microcirculatory tone [A19747]. …
Triciribine
Triciribine has been used in trials studying the treatment of Leukemia, Ovarian Cancer, HER2/Neu Negative, Breast Adenocarcinoma, and Stage IV Breast Cancer, among others.
Investigational
Matched Description: … Triciribine has been used in trials studying the treatment of Leukemia, Ovarian Cancer, HER2/Neu Negative …
Displaying drugs 10001 - 10025 of 12591 in total